FDA Issues Guidance on Trial Design for Hypogonadism Drugs

Drug Industry Daily
A A
A new FDA draft guidance outlines clinical trial designs for treatments of male hypogonadotropic hypogonadism, including enrollment criteria and efficacy endpoints.

To View This Article:

Login

Subscribe To Drug Industry Daily